Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of magnesium sulfate, ondansetron, metoclopramide, and low-dose propofol for reducing propofol injection pain in gynecologic surgery
IRCT2017031433069N1Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of magnesium sulfate, ondansetron, metoclopramide and propofol in propofol injection site pain (PISP) (4 arms), sponsored by Guilan University of Medical Sciences. Primary endpoint: Pain severity due to propofol injection. Started Apr 2017; status: completed.
02
Drugs
magnesium sulfateondansetronmetoclopramidepropofol
03
Conditions
propofol injection site pain (PISP)
Beyond the preview
Go deeper on IRCT2017031433069N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017031433069N1.